Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects

European Journal of Endocrinology

Volumn 169, Issue 1, 2013, Pages 37-43

  De Rosa, Anna ^a   Ludovica Monaco, Maria ^a,b   Capasso, Mario ^a,c   Forestieri, Pietro ^c   Pilone, Vincenzo ^c   Nardelli, Carmela ^a,c   Buono, Pasqualina ^b,d   Daniele, Aurora ^b,e  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OLIGOMER; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL FILTRATION; HUMAN; HUMAN TISSUE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WEIGHT REDUCTION; WESTERN BLOTTING;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BODY MASS INDEX; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GEL; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; WEIGHT LOSS;

EID: 84879989100     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-1039     Document Type: Article

References (37)

1. Turer AT &Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012 55 2319-2326. (doi:10.1007/s00125-012-2598-x)
2. Kadowaki T &Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 439-451. (doi:10.1210/ er.2005-0005)
3. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K &Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 1784-1792. (doi:10.1172/JCI29126)
4. Takeuchi T, Adachi Y, Ohtsuki Y &Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Medical Molecular Morphology 2007 40 115-120. (doi:10.1007/s00795-007- 0364-9)
5. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuser JE &Lodish HF. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. Journal of Biological Chemistry 2003 278 50810-50817. (doi:10.1074/jbc.M30 9469200)
6. Daniele A, De Rosa A, Nigro E, Scudiero O, Capasso M, Masullo M, de Laurentiis G, Oriani G, Sofia M &Bianco A. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. International Journal of Biochemistry &Cell Biology 2012 44 563-569. (doi:10.1016/ j.biocel.2011.12.016)
7. Daniele A, De Rosa A, De Cristofaro M, Monaco ML, Masullo M, Porcile C, Capasso M, Tedeschi G, Oriani G &Di Costanzo A. Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. European Journal of Endocrinology 2011 165 969-975. (doi:10.1530/EJE- 11-0537)
8. Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T &Node K. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. American Journal of Cardiology 2007 100 569-574. (doi:10.1016/j.amjcard.2007.03.062)
9. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004 279 12152-12162. (doi:10.1074/jbc.M311113200)
10. Bobbert T, Weicht J, Mai K, Mohlig M, Pfeiffer AF &Spranger J. Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers. Clinical Endocrinology 2009 71 507-511. (doi:10.1111/j.1365-2265. 2008.03519.x)
11. Hamilton MP, Gore MO, Ayers CR, Xinyu W, McGuire DK &Scherer PE. Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution. Diabetes &Vascular Disease Research 2011 8 190-194. (doi:10.1177/1479164111407784)
12. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S &Kadowaki T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005 146 790-796. (doi:10.1210/en.2004-1096)
13. Bobbert P, Antoniak S, Schultheiss HP &Rauch U. Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. Journal of Molecular and Cellular Cardiology 2008 44 388-394. (doi:10.1016/j.yjmcc. 2007.10.018)
14. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. Journal of Allergy and Clinical Immunology 2008 121 326-330. (doi:10.1016/j.jaci.2007.10.018)
15. Lang K . Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Communication and Signaling 2009 23 7-27. (doi:10.1186/1478-811X-7-27)
16. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE &Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 2001 98 2005-2010. (doi:10.1073/pnas.98.4.2005)
17. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK &de Lemos JA. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. Journal of the American Medical Association 2012 308 150-159. (doi:10.1001/2012.jama.11132)
18. Kovacova Z, Tencerova M, Roussel B,Wedellova Z, Rossmeislova L, Langin D, Polak J &Stich V. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. International Journal of Obesity 2012 36 1360-1365. (doi:10.1038/ijo.2011.223)
19. Matsuzawa Y. The role of fat topology in the risk of disease. International Journal of Obesity 2008 32 (Suppl 7) S83-S92. (doi:10.1038/ijo. 2008.243)
20. Hammes TO, Costa Cdos S, Rohden F, Margis R, de Almeida JC, Padoin AV, Mottin CC &Guaragna RM. Parallel down-regulation of FOXO1, PPARg and adiponectin mRNA expression in visceral adipose tissue of class III obese individuals. Obesity Facts 2012 5 452-459. (doi:10.1159/000339574)
21. Yang WS, Chen MH, Lee WJ, Lee KC, Chao CL, Huang KC, Chen CL, Tai TY &Chuang LM. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. International Journal of Obesity andRelated Metabolic Disorders 2003 27896-900. (doi:10.1038/sj.ijo.0802367)
22. Altomonte J, Harbaran S, Richter A &Dong H. Fat depotspecific expression of adiponectin is impaired in Zucker fatty rats. Metabolism: Clinical and Experimental 2003 52 958-963. (doi:10.1016/S0026-0495(03)00092-1)
23. Daniele A, Cammarata R, Masullo M, Nerone G, Finamore F, D'Andrea M, Pilla F &Oriani G. Analysis of adiponectin gene and comparison of its expression in two different pig breeds. Obesity 2008 16 1869-1874. (doi:10.1038/oby.2008.275)
24. Lin H &Li Z. Adiponectin self-regulates its expression and multimerization in adipose tissue: an autocrine/paracrine mechanism? Medical Hypotheses 2012 78 75-78. (doi:10.1016/j.mehy. 2011.07.063)
25. Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Madec S, Mancini E, Baldi S, Santini F, Pinchera A, Rossi M et al. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. International Journal of Obesity 2007 31 1843-1848. (doi:10.1038/sj.ijo. 0803676)
26. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M &Richelsen B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 2006 14 28-35. (doi:10.1038/oby.2006.5)
27. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP &Lambert GW. Surgical approaches to the treatment of obesity. Nature Reviews. Gastroenterology and Hepatology 2011 8 429-437. (doi:10.1038/ nrgastro.2011.112)
28. Linscheid P, Christ-Crain M, Stoeckli R, Reusch CE, Lutz TA, Muller B &Keller U. Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss. Diabetes, Obesity &Metabolism 2008 10 1266-1270. (doi:10.1111/j.1463-1326. 2008.00899.x)
29. Swarbrick MM, Austrheim-Smith IT, Stanhope KL, Van Loan MD, Ali MR, Wolfe BM &Havel PJ. Circulating concentrations of high-molecular-weight adiponectin are increased following Rouxen- Y gastric bypass surgery. Diabetologia 2006 49 2552-2558. (doi:10.1007/s00125-006-0452-8)
30. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F et al. Maternal serum adiponectin multimers in patients with a smallfor- gestational-age newborn. Journal of Perinatal Medicine 2009 37 623-635. (doi:10.1515/JPM.2009.128)
31. Daniele A, Cammarata R, Pasanisi F, Finelli C, Salvatori G, Calcagno G, Bracale R, Labruna G, Nardelli C, Buono P et al. Molecular analysis of the adiponectin gene in severely obese patients from southern Italy. Annals of Nutrition and Metabolism 2008 53 155-161. (doi:10.1159/000172976)
32. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R &Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 1357-1362. (doi:10.2337/dc05-1801)
33. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF &Patsch JR. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. European Journal of Clinical Investigation 2008 38 827-834. (doi:10.1111/j.1365-2362.2008.02028.x)
34. Benedix F, Westphal S, Patschke R, Granowski D, Luley C, Lippert H &Wolff S. Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obesity Surgery 2011 21 616-624. (doi:10.1007/s11695-011-0374-5)
35. Engl J, Bobbert T, Ciardi C, Laimer M, Tatarczyk T, Kaser S, Weiss H, Molnar C, Tilg H, Patsch JR et al. Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity 2007 15 1172-1178. (doi:10.1038/oby. 2007.627)
36. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, Lodish HF &Ruderman NB. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. PNAS 2002 99 16309-16313. (doi:10.1073/pnas. 222657499)
37. Almer G, Saba-Lepek M, Haj-Yahya S, Rohde E, Strunk D, Frohlich E, Prassl R &Mangge H. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions. Biologics 2011 5 95-105. (doi:10.2147/BTT.S22863)